Co-Authors
This is a "connection" page, showing publications co-authored by Ira Longini and Natalie Dean.
Connection Strength
2.574
-
Ensemble forecast modeling for the design of COVID-19 vaccine efficacy trials. Vaccine. 2020 10 27; 38(46):7213-7216.
Score: 0.903
-
DESIGN OF VACCINE TRIALS DURING OUTBREAKS WITH AND WITHOUT A DELAYED VACCINATION COMPARATOR. Ann Appl Stat. 2018 Mar; 12(1):330-347.
Score: 0.758
-
Factors Associated With Household Transmission of SARS-CoV-2: An Updated Systematic Review and Meta-analysis. JAMA Netw Open. 2021 08 02; 4(8):e2122240.
Score: 0.240
-
Household Transmission of SARS-CoV-2: A Systematic Review and Meta-analysis. JAMA Netw Open. 2020 12 01; 3(12):e2031756.
Score: 0.229
-
Household transmission of SARS-CoV-2 and risk factors for susceptibility and infectivity in Wuhan: a retrospective observational study. Lancet Infect Dis. 2021 05; 21(5):617-628.
Score: 0.058
-
Modelling the impact of testing, contact tracing and household quarantine on second waves of COVID-19. Nat Hum Behav. 2020 09; 4(9):964-971.
Score: 0.056
-
Household secondary attack rate of COVID-19 and associated determinants in Guangzhou, China: a retrospective cohort study. Lancet Infect Dis. 2020 10; 20(10):1141-1150.
Score: 0.055
-
An online decision tree for vaccine efficacy trial design during infectious disease epidemics: The InterVax-Tool. Vaccine. 2019 07 18; 37(31):4376-4381.
Score: 0.052
-
Quantifying the risk of local Zika virus transmission in the contiguous US during the 2015-2016 ZIKV epidemic. BMC Med. 2018 10 18; 16(1):195.
Score: 0.049
-
Ring vaccination with rVSV-ZEBOV under expanded access in response to an outbreak of Ebola virus disease in Guinea, 2016: an operational and vaccine safety report. Lancet Infect Dis. 2017 12; 17(12):1276-1284.
Score: 0.046
-
Spread of Zika virus in the Americas. Proc Natl Acad Sci U S A. 2017 05 30; 114(22):E4334-E4343.
Score: 0.045
-
Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!). Lancet. 2017 02 04; 389(10068):505-518.
Score: 0.044
-
Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial. Lancet. 2015 Aug 29; 386(9996):857-66.
Score: 0.040